feed,title,long_url,short_url
MedRxiv,Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study,https://medrxiv.org/cgi/content/short/2024.07.15.24310384v1?rss=1,https://da.gd/7rLjGR
MedRxiv,Clinical and cost-effectiveness of diverse post-hospitalisation pathways for COVID-19: A UK evaluation utilising the PHOSP-COVID cohort,https://medrxiv.org/cgi/content/short/2024.07.15.24310151v1?rss=1,https://da.gd/hTrK8g
